Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Congress Hub
Toolkit
Paediatric Growth Calculator
DVT Risk Calculator
Due Date Calculator
Mean Arterial Pressure (MAP) Calculator
BMI Calculator
Collaborate
About
EQOH
Careers
Contact Us
Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Work with Us
EMJ Interactive
EMJ GOLD
CME
search
Join
FREE
This site is intended for healthcare professionals
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Congress Hub
Toolkit
Paediatric Growth Calculator
DVT Risk Calculator
Due Date Calculator
Mean Arterial Pressure (MAP) Calculator
BMI Calculator
Collaborate
About
EQOH
Careers
Contact Us
Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Work with Us
EMJ Interactive
EMJ GOLD
CME
Join
FREE
Search type
Keyword
Author
Edition
European
US
Microbiology & Infectious Diseases
Filter
Journals
About
Congress reviews
Abstracts
Articles
Interviews
Podcasts
Videos & Webinars
News
Infographics
Society updates
Submit A Paper
Early Antibiotic Discontinuation Shows Promise in Febrile Neutropenia
October 2026
Early antibiotic discontinuation in febrile neutropenia reduced antibiotic exposure without increasing severe outcomes in interim trial findings.
Read more
31 Oct 2026
Early Antibiotic Discontinuation Shows Promise in Febrile Neutropenia
Early antibiotic discontinuation in febrile neutropenia reduced antibiotic exposure without increasing severe outcomes in interim trial findings.
29 Oct 2026
Ebola Vaccine Trial Begins as Congo Outbreak Deaths Rise
A Phase II/III Ebola vaccine trial has begun in Congo as the Bundibugyo outbreak approaches 4,800 deaths
27 Oct 2026
Infective Endocarditis After TAVR Is Less Common Than After SAVR
Infective endocarditis after TAVR was significantly less frequent than after surgical valve replacement, US electronic records show.
24 Oct 2026
Household Exposure Demands Universal Hep B Vaccination: IDWeek 2026
Household contacts drive over half of all infant hepatitis B exposures, challenging selective neonatal vaccination recommendations.
24 Oct 2026
Shorter Tuberculosis Treatment Shows Promising Results: IDWeek 2026
A four-month tuberculosis treatment regimen showed comparable efficacy and safety to standard six-month therapy in selected patients.
23 Oct 2026
HPV Vaccine Initiation at Ages 9–10 Maximizes Protection: IDWeek 2026
Initiating pediatric HPV vaccination at ages 9–10 significantly accelerates adolescent series completion rates before age thirteen.
22 Oct 2026
AMR Linked to $3.5 Trillion in Global Losses: IDWeek 2026
Antimicrobial resistance was linked to $3.5 trillion in global economic losses in 2021, new research reveals.
21 Oct 2026
Long-Acting HIV Treatment Maintains 94% Viral Suppression: IDWeek 2026
Long-acting HIV treatment maintained viral suppression in 94% of patients, with confirmed virologic failure occurring in just 1%.
Loading posts...
1
2
3
…
45
Next »
We’ve noticed you’re accessing
from
North/South America.
View
View